Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Catecholamine-sensitive guanylate cyclase from human caudate nucleus.

W H Frey, S E Senogles, L L Heston

    Journal of Neurochemistry
    |December 1, 1980
    PubMed
    Summary

    Dopamine and related catecholamines significantly inhibit soluble guanylate cyclase activity. This inhibition, competitive with MgGTP, is structure-dependent and occurs in both soluble and microsomal enzyme forms.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Intranasal deferoxamine affects memory loss, oxidation, and the insulin pathway in the streptozotocin rat model of Alzheimer's disease.

    Journal of the neurological sciences·2017
    Same author

    Intranasally-administered deferoxamine mitigates toxicity of 6-OHDA in a rat model of Parkinson׳s disease.

    Brain research·2014
    Same author

    Intranasal deferoxamine improves performance in radial arm water maze, stabilizes HIF-1α, and phosphorylates GSK3β in P301L tau transgenic mice.

    Experimental brain research·2012
    Same author

    Intranasal delivery of insulin and a nitric oxide synthase inhibitor in an experimental model of amyotrophic lateral sclerosis.

    Neuroscience·2008
    Same author

    Delivery of interferon-beta to the monkey nervous system following intranasal administration.

    Neuroscience·2008
    Same author

    Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype.

    Neurobiology of aging·2005

    Area of Science:

    • Biochemistry
    • Enzymology
    • Pharmacology

    Background:

    • Soluble guanylate cyclase (sGC) is a key enzyme in cellular signaling pathways.
    • Understanding modulators of sGC activity is crucial for therapeutic development.

    Purpose of the Study:

    • To investigate the effect of dopamine and related catecholamines on partially purified soluble guanylate cyclase.
    • To characterize the mechanism and structural requirements of catecholamine-mediated inhibition.

    Main Methods:

    • Partial purification of soluble guanylate cyclase using DEAE-Sephacel chromatography.
    • Enzyme activity assays with varying catecholamine concentrations and metal cofactors.
    • Investigating inhibition kinetics and structural specificity.

    Related Experiment Videos

    Main Results:

    • Dopamine markedly inhibits partially purified sGC (I50 = 0.2 microM), with inhibition observed under various conditions.
    • A range of catecholamines showed inhibitory effects, with specific structural features required.
    • Dopamine inhibition was competitive with MgGTP and rapidly reversible by dilution.

    Conclusions:

    • Dopamine and other catecholamines are potent inhibitors of soluble guanylate cyclase.
    • The study elucidates structural requirements for inhibition and suggests a non-redox, non-covalent mechanism.
    • Findings provide insights into the regulation of guanylate cyclase by catecholamines.